Back to Authors

Eckloff, Bruce

Mayo Clinic

Advanced Genomics Technology Center, Mayo Clinic, Rochester, MN, USA.

Citations 2

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Braggio, Esteban , Wier, Scott Van, Ojha, Juhi, McPhail, Ellen D. , Asmann, Yan W. , Egan, Jan B. , Ayres-Silva, Jackline de Paula , Schiff, David , Lopes, M. Beatriz S. , Decker, Paul A. , Valdez, Riccardo, Tibes, Raoul , Eckloff, Bruce W., Stewart, A. Keith, Van Wier, Scott, McPhail, Ellen, Egan, Jan, Eckloff, Bruce, O'Neill, Brian Patrick, McPhail, Ellen Darcy , Decker, Paul A. , Witzig, Thomas E. , Fonseca, Rafaël , O’Neill, Brian Patrick , Braggio, Esteban

Clinical Cancer Research | May 19, 2015 | Volume: 21 | Issue: 17 | Pages: 3986-3994

10.1158/1078-0432.ccr-14-2116 Get It

Abstract Purpose: Primary central nervous system lymphoma (PCNSL) is an aggressive non-Hodgkin lymphoma confined to the central nervous system. Whether there is a PCNSL-specific genomic signature and, if so, how it differs from systemic diffuse large B-cell lymphoma (DLBCL) is uncertain. Experimental Design: We performed a comprehensive genomic study of tumor samples from 19 immunocompetent PCNSL patients. Testing comprised array-comparative genomic hybridization and whole exome sequencing. Results: Biallelic inactivation of TOX and PRKCD was recurrently found in PCNSL but not in systemic DLBCL, suggesting a specific role in PCNSL pathogenesis. In addition, we found a high prevalence of MYD88 mutations (79%) and CDKN2A biallelic loss (60%). Several genes recurrently affected in PCNSL were common with systemic DLBCL, including loss of TNFAIP3, PRDM1, GNA13, TMEM30A, TBL1XR1, B2M, CD58, activating mutations of CD79B, CARD11, and translocations IgH-BCL6. Overall, B-cell receptor/Toll-like receptor/NF-κB pathways were altered in >90% of PNCSL, highlighting its value for targeted therapeutic approaches. Furthermore, integrated analysis showed enrichment of pathways associated with immune response, proliferation, apoptosis, and lymphocyte differentiation. Conclusions: In summary, genome-wide analysis uncovered novel recurrent alterations, including TOX and PRKCD, helping to differentiate PCNSL from systemic DLBCL and related lymphomas. Clin Cancer Res; 21(17); 3986–94. ©2015 AACR.
Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity
Yadav, Vinod Kumar , Thakur, Ram Krishna, Eckloff, Bruce W., Baral, Aradhita, Singh, Ankita, Halder, Rashi , Kumar, Akinchan, Alam, Mohammad P., Kundu, Tapas K. , Pandita, Raj K., Pandita, Tej K. , Wieben, Eric D. , Chowdhury, Shantanu , Eckloff, Bruce

Nucleic Acids Research | August 1, 2014 | Volume: 42 | Issue: 15 | Pages: 9602-9611

10.1093/nar/gku596 Get It

Abstract Previous studies have analyzed patterns of transcription, transcription factor (TF) binding or mapped nucleosome occupancy across the genome. These suggest that the three aspects are genetically connected but the cause and effect relationships are still unknown. For example, physiologic TF binding studies involve many TFs, consequently, it is difficult to assign nucleosome reorganization to the binding site occupancy of any particular TF. Therefore, several aspects remain unclear: does TF binding influence nucleosome (re)organizations locally or impact the chromatin landscape at a more global level; are all or only a fraction of TF binding a result of reorganization in nucleosome occupancy and do all TF binding and associated changes in nucleosome occupancy result in altered gene expression? With these in mind, following characterization of two states (before and after induction of a single TF of choice) we determined: (i) genomic binding sites of the TF, (ii) promoter nucleosome occupancy and (iii) transcriptome profiles. Results demonstrated that promoter-proximal TF binding influenced expression of the target gene when it was coupled to nucleosome repositioning at or close to its binding site in most cases. In contrast, only in few cases change in target gene expression was found when TF binding occurred without local nucleosome reorganization.